The 2018 American Heart Association/American Stroke Association (AHA/ASA) guidelines stated that the administration of intravenous recombinant tissue-type plasminogen activator (rTPA) for acute ischaemic stroke is probably safe for patients with small (i.e. <10 mm) unruptured intracranial aneurysms. We present 2 cases of small (2 and 5 mm) lenticulostriate artery (LSA) aneurysms which ruptured immediately following rtPA infusion. The ensuing acute intracranial haemorrhages resulted in the death of one patient and severe functional impairment for the other. Given the limited literature available, the natural history of LSA aneurysms is largely unknown. This report suggests that LSA aneurysms, regardless of size, be considered separately from other conventional aneurysms as "high-risk" lesions and a contraindication to thrombolysis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jocn.2018.10.087 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Post-thrombolysis rupture of small lenticulostriate aneurysms: A report of 2 consecutive cases.
J Clin Neurosci
February 2019
Department of Neurology, National Neuroscience Institute, Singapore.
The 2018 American Heart Association/American Stroke Association (AHA/ASA) guidelines stated that the administration of intravenous recombinant tissue-type plasminogen activator (rTPA) for acute ischaemic stroke is probably safe for patients with small (i.e. <10 mm) unruptured intracranial aneurysms.
View Article and Find Full Text PDFIs acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm?
Int J Stroke
October 2015
Department of Neurosurgery, University at Buffalo, State University of New York, Buffalo, NY, USA.
Background: Intracranial aneurysms are currently considered as contraindication for intravenous thrombolysis in acute ischemic stroke, very likely due to a possible increase in the risk of bleeding from aneurysm rupture; however, there is limited data available on whether intravenous thrombolysis is safe for acute ischemic stroke patients with pre-existing intracranial aneurysms.
Aims And/or Hypothesis: To find out the safety of intravenous thrombolysis in acute ischemic stroke patients who harbor unruptured intracranial aneurysms.
Methods: We retrospectively reviewed the medical records and cerebrovascular images of all the patients treated with intravenous thrombolysis for acute ischemic stroke in our center from the beginning of 2006 till the end of April 2014.
Rupture of a concealed aneurysm after intravenous thrombolysis of a thrombus in the parent middle cerebral artery.
J Stroke Cerebrovasc Dis
March 2015
Service de Neurochirurgie, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
Background: Management of ischemic stroke in the presence of aneurysmal brain disease is controversial. Recent retrospective evidence suggests that in selected patients, intravenous thrombolysis (IVT) remains a safe approach for reperfusion.
Methods: We document a case of post-thrombolysis aneurysmal rupture.
Thrombogenesis and inhibition of platelet aggregation. Experimental aspects and future approaches.
Z Kardiol
July 1991
Division of Cardiology, Mount Sinai School of Medicine, New York.
The pathophysiology of the acute coronary syndromes and of the progression of chronic coronary artery disease is complex, but in most cases it appears to be based on fixed atherosclerotic coronary disease with plaque rupture and superimposed thrombosis commonly followed by its organization by connective tissue. Furthermore, spontaneous or therapeutic reperfusion may be followed by re-thrombosis, as it may occur in reocclusion post-thrombolysis, which is another pathologic event of significant clinical importance. The mechanisms of thrombus formation in atherosclerosis are not fully understood, but clearly involve local blood flow conditions, in addition to vascular and blood-borne factors that regulate cell-substrate and cell-cell interactions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!